Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Balabaud

Showing results (121-130 of 162) with videos related to

Pageof 17
Sort By:
Hepatology (Baltimore, Md.)|August 1, 2007
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistryPaulette Bioulac-Sage, Sandra Rebouissou, Cristel Thomas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 31, 2015
Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosisJulien Calderaro, Jean C Nault, Charles Balabaud, et al.
Nature Genetics|October 2, 2002
Bi-allelic inactivation of TCF1 in hepatic adenomasOlivier Bluteau, Emmanuelle Jeannot, Paulette Bioulac-Sage, et al.
Histopathology|November 19, 2013
Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?Claire Castain, Christine Sempoux, Elizabeth M Brunt, et al.
Gastroenterology|November 5, 2003
Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivationYannick Bacq, Emmanuel Jacquemin, Charles Balabaud, et al.
Gastroenterology|May 12, 2005
Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liverPaulette Bioulac-Sage, Sandra Rebouissou, Antonio Sa Cunha, et al.
Diabetes|April 16, 2010
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damageEmmanuelle Jeannot, Lucille Mellottee, Paulette Bioulac-Sage, et al.
Hepatology (Baltimore, Md.)|November 11, 2010
A protective role for CD154 in hepatic steatosis in miceJulien Villeneuve, Sébastien Lepreux, Audrey Mulot, et al.
Hepatology (Baltimore, Md.)|July 9, 2009
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experiencePaulette Bioulac-Sage, Hervé Laumonier, Gabrielle Couchy, et al.
The Journal of Experimental Medicine|June 22, 2011
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomasCamilla Pilati, Mohamed Amessou, Michel P Bihl, et al.
Pageof 17

Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|August 1, 2007
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistryPaulette Bioulac-Sage, Sandra Rebouissou, Cristel Thomas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 31, 2015
Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosisJulien Calderaro, Jean C Nault, Charles Balabaud, et al.
Nature Genetics|October 2, 2002
Bi-allelic inactivation of TCF1 in hepatic adenomasOlivier Bluteau, Emmanuelle Jeannot, Paulette Bioulac-Sage, et al.
Histopathology|November 19, 2013
Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?Claire Castain, Christine Sempoux, Elizabeth M Brunt, et al.
Gastroenterology|November 5, 2003
Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivationYannick Bacq, Emmanuel Jacquemin, Charles Balabaud, et al.
Gastroenterology|May 12, 2005
Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liverPaulette Bioulac-Sage, Sandra Rebouissou, Antonio Sa Cunha, et al.
Diabetes|April 16, 2010
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damageEmmanuelle Jeannot, Lucille Mellottee, Paulette Bioulac-Sage, et al.
Hepatology (Baltimore, Md.)|November 11, 2010
A protective role for CD154 in hepatic steatosis in miceJulien Villeneuve, Sébastien Lepreux, Audrey Mulot, et al.
Hepatology (Baltimore, Md.)|July 9, 2009
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experiencePaulette Bioulac-Sage, Hervé Laumonier, Gabrielle Couchy, et al.
The Journal of Experimental Medicine|June 22, 2011
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomasCamilla Pilati, Mohamed Amessou, Michel P Bihl, et al.
Pageof 17